Ophthalmic Drugs Already Lead Medicare Part B Cost Drivers: How Will Gene Therapy Fit?

 
• By Cathy Kelly
  
Ophthalmic drugs are A Growing Treatment Category. • Source: Shutterstock

More from Market Access

More from Pink Sheet